Proteo‐genomics of soluble TREM2 in cerebrospinal fluid provides novel insights for TREM2 biology and identifies novel modulators for Alzheimer's disease.

MLA

Wang, Lihua, et al. “Proteo‐genomics of Soluble TREM2 in Cerebrospinal Fluid Provides Novel Insights for TREM2 Biology and Identifies Novel Modulators for Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, Dec. 2023, pp. 1–2. EBSCOhost, https://doi.org/10.1002/alz.077275.

APA

Wang, L., Nykanen, N., Western, D., Gorijala, P., Timsina, J., Marquié, M., Boada, M., Alvarez, I., Aguilar, M., Pastor, P., Ruiz, A., Hohman, T. J., Wyss, C. T., Sung, Y. J., & Cruchaga, C. (2023). Proteo‐genomics of soluble TREM2 in cerebrospinal fluid provides novel insights for TREM2 biology and identifies novel modulators for Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19, 1–2. https://doi.org/10.1002/alz.077275

Chicago

Wang, Lihua, Niko‐Petteri Nykanen, Daniel Western, Priyanka Gorijala, Jigyasha Timsina, Marta Marquié, Mercè Boada, et al. 2023. “Proteo‐genomics of Soluble TREM2 in Cerebrospinal Fluid Provides Novel Insights for TREM2 Biology and Identifies Novel Modulators for Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (December): 1–2. doi:10.1002/alz.077275.